PlexusDx semaglutide injections include B12 formulation options to reduce the fatigue some patients experience when starting GLP-1 therapy
The utility of putative blood biomarkers, including glial fibrillary acidic protein (GFAP), ubiquitin carboxy-terminal hydrolase L1 (UCH-L1), S100 calcium-binding protein B (S100B) and Neurofilament-light (NF-L), has been evaluated by multicenter studies such as ALERT, CENTER-TBI, TRACK-TBI and BIO-AX-TBI [5, 21]
Eur J Pharm Sci 104:3141 Jensen L, Kupcova V, Arold G, Pettersson J, Hjerpsted JB (2018) Pharmacokinetics and tolerability of semaglutide in people with hepatic impairment
Understanding these risks is essential for both healthcare professionals and patients
N Engl J Med 2015;373:211728